Percutaneous Coronary Intervention in a Patient with Acute Thrombosis of Saphenous Vein Graft and Patent Native Coronary Artery: Which is the Vessel to Approach?

Marco Ferrone; Anna Franzone; Bruno Trimarco; Giovanni Esposito; Plinio Cirillo

doi:10.3934/medsci.2015.4.310

AIMS Medical Science, 2015, 2(4): 310-315. doi: 10.3934/medsci.2015.4.310. Case report Special Issues

Export file:

Format

RIS(for EndNote,Reference Manager,ProCite)
BibTex
Text

Content

Citation Only
Citation and Abstract

Percutaneous Coronary Intervention in a Patient with Acute Thrombosis of Saphenous Vein Graft and Patent Native Coronary Artery: Which is the Vessel to Approach?

Marco Ferrone, Anna Franzone, Bruno Trimarco, Giovanni Esposito, Plinio Cirillo

Division of Cardiology, Department of Advanced Biomedical Sciences, School of Medicine, "Federico II" University, Naples, Italy

Received date: , Accepted date: , Published date:

Special Issues: Coronary artery disease and role of percutaneous interventions

Abstract Full Text(HTML) Figure/Table Related pages

We describe a case of a patient with a clinical history of coronary artery disease, previously treated by coronary surgery and, one year later, by percutaneous coronary intervention plus stenting for sub-occlusive disease of the saphenous vein graft to first obtuse marginal (OM) branch. The patient, admitted to our emergency room with chest pain, nausea, hypotension and diaphoresis, had elevated blood levels of cardiac troponin T and EKG showed elevation of the ST segment in the in lateral leads, suggesting a diagnosis of ST elevated myocardial infarction (STEMI). Thus, coronary angiography was immediately performed, showing the massive thrombosis of the saphenous vein graft previously treated by stenting and the slight patency of the native vessel. We decided to approach the native vessel instead of clashing to the massive thrombus of the saphenous vein graft, overcoming the actual guidelines indications.

Figure/Table

Supplementary

Article Metrics

Keywords: acute myocardial infarction; PCI; saphenous vein graft; vessel thrombosis

Citation: Marco Ferrone, Anna Franzone, Bruno Trimarco, Giovanni Esposito, Plinio Cirillo. Percutaneous Coronary Intervention in a Patient with Acute Thrombosis of Saphenous Vein Graft and Patent Native Coronary Artery: Which is the Vessel to Approach?. AIMS Medical Science, 2015, 2(4): 310-315. doi: 10.3934/medsci.2015.4.310

References:

1.Yap CH, Sposato L, Akowuah E, et al. (2009) Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann Thorac Surg 87(5): 1386-1391.
2.Sarwar B, Brener SJ (2014) Saphenous vein graft interventions. Curr Treat Options Cardiovasc Med 16(5): 301.
3.Brilakis ES, Lichtenwalter C, Abdel-karim AR, et al. (2011) Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. JACC Cardiovasc Interv 4(2): 176-182.
4.Xanthopoulou I, Davlouros P, Tsigkas G, et al. (2011) Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting. Can J Cardiol 27(6): 716-724.
5.Hoffmann R, Nitendo G, Deserno V, et al. (2010) Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion. Coron Artery Dis 21(2): 61-64.
6.Yeh RW, Sidney S, Chandra M, et al. (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362(23): 2155-2165.
7.Abdel-Karim AR, Banerjee S, Brilakis ES (2010) Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes. J Invasive Cardiol 22(6): 253-257.
8.Gaglia MA, Torguson R, Xue Z, et al. (2011) Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 78(1): 23-29.
9.Mehilli J, Pache J, Abdel-Wahab M, et al. (2011) Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. Lancet 378(9796): 1071-1078.
10. Vermeersch P, Agostoni P, Verheye S, et al. (2007) Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol 50(3): 261-267.
11. Costopoulos C, Latib A, Naganuma T, et al. (2013) Comparison of first- and second-generation drug-eluting stents in saphenous vein grafts used as aorto-coronary conduits. Am J Cardiol 112(3): 318-322.
12. Taniwaki M, Räber L, Magro M, et al. (2014) Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts. EuroIntervention 9(12): 1432-1434.
13. Kitabata H, Loh JP, Pendyala LK, et al. (2013) Two-year follow-up of outcomes of second-generation everolimus-eluting stents versus first-generation drug-eluting stents for stenosis of saphenous vein grafts used as aortocoronary conduits. Am J Cardiol 112(1): 61-67.

show all references

Reader Comments

your name: * your email: *

Copyright Info: 2015, Plinio Cirillo, et al., licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Associated material

Metrics